title: Pilot randomized, non-inferiority, cross-over trial of once-weekly vs. three times-weekly recombinant factor VIII prophylaxis in adults with severe haemophilia A.
authors.affiliation: Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.|Hemophilia Center of Western Pennsylvania, Pittsburgh, PA, USA.
authors.forename: M V
authors.initials: MV
authors.lastname: Ragni
authors.affiliation: Center for Research on Health Care Data Center, University of Pittsburgh, Pittsburgh, PA, USA.
authors.forename: J G
authors.initials: JG
authors.lastname: Yabes
authors.affiliation: University of Pennsylvania, Philadelphia, PA, USA.
authors.forename: P F
authors.initials: PF
authors.lastname: Fogarty
authors.affiliation: Puget Sound Blood Center, Seattle, WA, USA.
authors.forename: N C
authors.initials: NC
authors.lastname: Josephson
authors.affiliation: Georgetown University Medical Center, Washington, DC, USA.
authors.forename: C M
authors.initials: CM
authors.lastname: Kessler
authors.affiliation: Vanderbilt University Medical Center, Nashville, TN, USA.
authors.forename: A T
authors.initials: AT
authors.lastname: Neff
authors.affiliation: Children's Hospital of Philadelphia, Philadelphia, PA, USA.
authors.forename: L
authors.initials: L
authors.lastname: Raffini
authors.affiliation: Department of Biochemistry, University of Vermont, Colchester, VT, USA.
authors.forename: K
authors.initials: K
authors.lastname: Brummel-Ziedins
authors.affiliation: Center for Research on Health Care Data Center, University of Pittsburgh, Pittsburgh, PA, USA.
authors.forename: C G
authors.initials: CG
authors.lastname: Moore
mesh_terms: D018592:Cross-Over Studies; D005169:Factor VIII / Q000627:therapeutic use*; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans; D008297:Male; D010865:Pilot Projects
chemical_list: D005169:Factor VIII